Walleye Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-649
| Closed | -$200K | – | 2305 |
|
|
2025
Q1 | $200K | Buy |
649
+323
| +99% | +$99.6K | ﹤0.01% | 1401 |
|
|
2024
Q4 | $115K | Sell |
326
-1,091
| -77% | -$385K | ﹤0.01% | 1658 |
|
|
2024
Q3 | $508K | Sell |
1,417
-7,675
| -84% | -$2.75M | ﹤0.01% | 1330 |
|
|
2024
Q2 | $2.9M | Buy |
9,092
+6,097
| +204% | +$1.94M | 0.01% | 651 |
|
|
2024
Q1 | $688K | Sell |
2,995
-11,912
| -80% | -$2.74M | ﹤0.01% | 1232 |
|
|
2023
Q4 | $3.28M | Buy |
+14,907
| New | +$3.28M | 0.01% | 478 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3004 |
|
|
2023
Q2 | – | Sell |
-18,574
| Closed | -$4.16M | – | 2867 |
|
|
2023
Q1 | $4.16M | Buy |
18,574
+14,441
| +349% | +$3.23M | 0.06% | 336 |
|
|
2022
Q4 | $1.15M | Sell |
4,133
-58,049
| -93% | -$16.1M | 0.02% | 661 |
|
|
2022
Q3 | $13M | Buy |
62,182
+47,122
| +313% | +$9.87M | 0.25% | 71 |
|
|
2022
Q2 | $3.55M | Sell |
15,060
-7,281
| -33% | -$1.72M | 0.1% | 226 |
|
|
2022
Q1 | $4.01M | Buy |
22,341
+20,332
| +1,012% | +$3.65M | 0.11% | 192 |
|
|
2021
Q4 | $434K | Sell |
2,009
-3,566
| -64% | -$770K | 0.01% | 1043 |
|
|
2021
Q3 | $1.03K | Buy |
+5,575
| New | +$1.03K | 0.03% | 410 |
|
|
2020
Q1 | – | Sell |
-490
| Closed | -$43K | – | 959 |
|
|
2019
Q4 | $43K | Buy |
490
+380
| +345% | +$33.3K | ﹤0.01% | 531 |
|
|
2019
Q3 | $9K | Hold |
110
| – | – | ﹤0.01% | 436 |
|
|
2019
Q2 | $9K | Sell |
110
-688
| -86% | -$56.3K | ﹤0.01% | 435 |
|
|
2019
Q1 | $94K | Buy |
+798
| New | +$94K | 0.02% | 158 |
|